Anzeige
❌
Mehr »
Dienstag, 17.11.2026 - Börsentäglich über 12.000 News
Milliardenmarkt Quantensicherheit! Ist diese Aktie noch völlig unterschätzt?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
VS

WKN: A427JE | ISIN: CA92244M1041 | Ticker:
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
VECTOR SCIENCE AND THERAPEUTICS CORP Chart 1 Jahr
5-Tage-Chart
VECTOR SCIENCE AND THERAPEUTICS CORP 5-Tage-Chart

Aktuelle News zur VECTOR SCIENCE AND THERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
00:18Vector Science and Therapeutics Corp: Vector Science to hold media briefing Nov. 181
23.10.Vector Science and Therapeutics Corp: Vector launches microneedle peptide delivery idea1
22.10.Vector Science and Therapeutics Corp. Introduces Peptide-Matrix Microneedle Technology for Targeted Transdermal Delivery of Peptides1
19.10.Vector Science and Therapeutics Corp: Vector adds Jackson as managing director, corp. dev.4
19.10.Vector Science and Therapeutics Corp. Appoints Angus Jackson as Managing Director of Corporate Development1
14.10.Vector Science and Therapeutics Corp: Vector Science appoints Starr as president1
VECTOR SCIENCE AND THERAPEUTICS Aktie jetzt für 0€ handeln
14.10.Vector Science & Therapeutics Corp. Appoints Russell Starr as President1
14.10.Vector Science appoints Russell Starr as president1
14.10.Vector Science and Therapeutics Corp: Vector invests in Whoopi Wellness through SAFE1
13.10.Vector Science and Therapeutics Corp. Announces Collaboration and SAFE Investment in Whoopi Wellness, Inc.1
08.10.Vector Science and Therapeutics Corp: Vector, Scoreboard to develop products for athletes1
07.10.Vector Sciences & Therapeutics: Vector Science and Therapeutics Corp. Announces Collaboration with SAFE Investment in Gary Payton's Scoreboard218Investment advances collaboration on peptide-based products for athletic performance, recovery and longevity TORONTO, Oct. 7, 2026 /PRNewswire/ -- Vector Science...
► Artikel lesen
26.09.Vector Science and Therapeutics Corp: Vector Science grants option to buy 150,000 shares3
26.09.Vector Science and Therapeutics Corp.: Vector Science and Therapeutics Corp. Issues Options1.117Mequon, Wisconsin--(Newsfile Corp. - September 25, 2026) - Vector Science and Therapeutics Corp. (TSXV: PAIN) ("Vector" or the "Company") today announced that the Board of Directors has approved the...
► Artikel lesen
26.08.Vector Science and Therapeutics Corp. Enters Into an Investor Relations Agreement and Grants Options1
26.08.Vector Science and Therapeutics Corp: Vector hires RedChip for investor relations services1
24.08.Vector Science & Therapeutics (TSXV: PAIN) Begins Peptide Production as First Suite at LyoGenesis Manufacturing Comes Online1
20.08.Vector Science and Therapeutics Corp: Vector files patent for peptide orthopedic platform2
20.08.Vector Sciences & Therapeutics: Vector Science and Therapeutics Corp. (TSXV: PAIN) Files Provisional Patent Application on Integrated Platform for Orthopedic Tissue Regeneration Using Peptides268Platform combines regenerative peptides with autologous platelet-rich biologics, alongside adjunct formulations designed to avoid interfering with the body's own...
► Artikel lesen
19.08.Vector Science and Therapeutics Corp: Vector Science launches quality analytical testing1
1 2 3 Weiter >>
46 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1